Chiron&#39;s vaccine plans in tatters and financial future in doubt
15915
EMERYVILLE, Calif. Chiron&#39;s (KY-rawn) aggressive plan to dominate the US flu vaccine market is in tatters. The Emeryville-based company&#39;s financial future is clouded now as well as the public health crisis it caused continues to mount.
482214
Chiron, the biotechnology company that left the US short of half its normal supply of flu vaccine this winter after contamination fears at its Speke factory in Liverpool, has
121348
The Food and Drug Administration has demanded more answers from Chiron Corp. about its efforts to correct operating flaws at the Liverpool plant, where half of the US flu vaccine for this winter was lost to contamination.
202202
The company that makes half the nation&#39;s supply, Chiron Corporation, has found four million tainted samples in its factory. It&#39;s postponing shipments of 50 million doses of vaccine until they&#39;re checked for safety.
104396
Federal regulators reportedly found manufacturing problems at Chiron&#39;s flu-vaccine plant in England last year similar to those that led British authorities to shut down the facility last week.
301378
The nation&#39;s supply of vaccine for the impending flu season took a big hit Thursday when Chiron Corp. announced it had found tainted doses in its factory.
288137
The sudden, major flu vaccine shortage that shocked health authorities last week highlights two vulnerabilities in the nation&#39;s immunization system: a reliance on a few private manufacturers that use old technology, and government&#39;s faith that companies
430526
The loss of one-half of the nation's expected flu vaccine inventory has sparked widespread public anxiety over where to find remaining vaccine and challenged health providers to get unshipped stocks to those who most need them.
225870
Chiron Corp., which had to scrap its  flu vaccine this season due to contamination, said on Friday it  has received a warning from U.S. regulators in connection with  its shuttered vaccine manufacturing plant in England.
628244
Just weeks ahead of flu season US health officials are scrambling to manage a record shortage of influenza vaccine. The US supply was cut in half Tuesday when British regulators abruptly shut down major flu-shot supplier Chiron Corp.
539761
GlaxoSmithKline PLC and Novartis AG, two of the world's biggest vaccine makers, may have bet on the wrong technology in the race to develop a better flu shot.
697264
(Washington-NBC) Nov. 17, 2004 - Chiron CEO Howard Pien spoke for the first time since Britain&#39;s MHRA shut his plant down in October and says despite government assurances, &quot;There can be no conclusive assurance
164503
Shares of Chiron Corp. CHIR.O fell 7  percent before the market open on Friday, a day after the  biopharmaceutical company said it is delaying shipment of its  flu vaccine, Fluvirin, because lots containing 4 million  vaccines do not meet product sterility standards.
708304
US vaccine manufacturer Chiron Corp., has hinted it might not be able to supply the United States with flu vaccine next year, the New York Times reports.
138973
The announcement came last week: Flu vaccine shortage. Chiron Corporationâs flu vaccine facility in Liverpool, England, had its license suspended for three months by British health regulators because of contamination problems.
266927
The unexpected suspension of Chiron&#39;s production of flu vaccine created a sudden shortage of the supply available to Americans.
555758
This year&#39;s unexpected shortage of flu vaccine was a result of vaccine doses becoming contaminated during production. On October 5th, Chiron Corporation, a California-based biotechnology